Successful treatment with adalimumab for autoimmune sensorineural hearing loss in a patient with Behçet's disease

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):164-165. Epub 2019 Jul 11.

Authors

Ayano Utsunomiya¹, Toshiyuki Watanabe², Ken Shizuki³, Satoshi Jodo¹

Affiliations

¹ Department of Internal Medicine, Tomakomai City Hospital, Tomakomai, Japan.
² Department of Internal Medicine, Tomakomai City Hospital, Tomakomai, Japan. nabe0727@med.hokudai.ac.jp.
³ Department of Otolaryngology, Tomakomai City Hospital, Tomakomai, Japan.

PMID: 31376253

No abstract available

Publication types

Letter

MeSH terms

Adalimumab / therapeutic use*
Autoimmune Diseases
Behcet Syndrome* / complications
Hearing Loss, Sensorineural* / drug therapy
Hearing Loss, Sensorineural* / etiology
Humans
Treatment Outcome

Substances

Adalimumab